Bruce G. Allen Investments’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$516K Sell
5,625
-133
-2% -$11.6K 0.33% 36
2026
Q1
$491K Buy
5,758
+198
+4% +$17.6K 0.32% 39
2025
Q4
$439K Buy
5,560
+99
+2% +$7.76K 0.3% 39
2025
Q3
$437K Sell
5,461
-101
-2% -$8.62K 0.31% 40
2025
Q2
$506K Sell
5,562
-34
-0.6% -$3.1K 0.38% 30
2025
Q1
$524K Hold
5,596
– – 0.42% 30
2024
Q4
$509K Buy
5,596
+295
+6% +$28.1K 0.41% 32
2024
Q3
$550K Sell
5,301
-54
-1% -$5.5K 0.43% 33
2024
Q2
$520K Buy
5,355
+362
+7% +$33.4K 0.44% 34
2024
Q1
$450K Buy
4,993
+109
+2% +$9.23K 0.37% 39
2023
Q4
$389K Buy
+4,884
New +$367K 0.35% 40

Other funds holding CL

Bruce G. Allen Investments's CL Position: Q2 2026 in Review

Bruce G. Allen Investments reduced its Colgate-Palmolive (CL) stake by 2.3% in Q2 2026, selling an estimated $11.6K and leaving 5,625 shares worth $516K. The position accounts for 0.33% of the portfolio, ranked #36.

Bruce G. Allen Investments first reported a position in CL in Q4 2023 and has held it in 11 quarters since. The position peaked at $550K in Q3 2024. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Bruce G. Allen Investments held 5,625 shares of Colgate-Palmolive worth $516K as of Q2 2026.
  • Bruce G. Allen Investments sold 133 Colgate-Palmolive shares in Q2 2026, an estimated $11.6K.
  • Colgate-Palmolive made up 0.33% of Bruce G. Allen Investments's portfolio in Q2 2026, its #36 holding.
  • Bruce G. Allen Investments first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
  • Bruce G. Allen Investments's Colgate-Palmolive position peaked at $550K in Q3 2024.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.